
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has garnered a mostly positive outlook among various experts, highlighting its competitive positioning within the Canadian financial sector, particularly in comparison to major banks like TD and SLF. Analysts note MFC's ongoing strength in wealth management and healthy growth prospects in Asia, although there are concerns regarding its current valuation, as it trades over 2x book value and exhibits only moderate earnings growth. Despite being classified as slightly overbought, its charts remain healthy, with many recommending caution yet seeing potential for growth in the long run. The company's strong dividend yield and management strategies, particularly in alternative investments, also contribute to a favorable long-term investment story, although short-term volatility may present opportunities for those willing to enter at lower price points.
Business headed in right direction. Profitability increasing, return on equity also strong. New management has turned things around. Current yield ~5% is very stable. Interest rates not a concern - have weather rising rates well. Would continue to buy - still owns shares.
Share price up nicely - a little strong, but overall very good trends.. Excellent balance sheet strength. Capital allocation very strong the past few years. Excellent CEO. Recently selling problematic assets. Seeing rebound in Asia market. Good for shareholders in the long term. Core holding in income portfolio.
Ranks a bit higher than SLF on his screens, but it's not by a significant amount. Exposure to Asia, a growing market. Yield is 4.9%, dividend should increase over time.
Some of the insurers are outperforming the banks because they're a bit more levered to falling interest rates, fewer credit concerns and loan-loss provisions. Likes banks, too.
Breaking out of a more than decade-long range. Finally have some fundamentals on LTC portfolio. Reinsurance deal was better than expected. Underlying business performing pretty well. Asia has both potential and potential risks. Not expensive. Have to see if the big institutional money moves in. Yield is 5.05%.
(Analysts’ price target is $31.11)It's popped slightly recently. They just did a deal in which they released $1.2 billion of free capital--this finally woke up people that MFC is a little undervalued. It still is at 8x PE with a price-to-book of 1.3x. Under this CEO in recent years, they've been streamlining operations to be more efficient and adding growth. This has been a top pick of his many times.
Their big product was guaranteeing a life insurance policy on stock returns. So, when the market melted down, there was a big scare. Now, the market has come back, and those policies won't lose as much. MFC used to be held up by a fortress balance sheet. 15 years later, they've grown into that balance sheet. Saw nice earnings growth in 2023 and expects it also for 2024.
(Analysts’ price target is $35.37)